[Double-blind clinical study: flunarizine versus pizotifen in a single nightly dose in hemicrania patients].
R. Cerbo, M. Casacchia, R. Formisanoa, M. G. Buzzia, B. Boni, M. Feliciani, G. Grillo, G. Cusimano, A. Agnoli
- aFondazione Santa Lucia
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
In this double-blind clinical trial we compared the prophylactic efficacy of the calcium-entry blocker flunarizine (15 mg nocte) with that of pizotifen (1,5 mg nocte). In 30 patients affected by classical and common migraine. During a two months treatment both drugs showed a good efficacy. Flunarizine tended to more markedly suppress severity of pain and duration of attacks than pizotifen. Daytime drowsiness and weight gain occurred with both drugs; the first side effect was more evident in the group treated with flunarizine, the second one in the group treated with pizotifen.
TL;DRFlunarizine tended to more markedly suppress severity of pain and duration of attacks than pizotifen, while daytime drowsiness and weight gain occurred with both drugs. (Semantic Scholar)